전체메뉴
Article Search

VSI Vascular Specialist International

Open Access

pISSN 2288-7970
eISSN 2288-7989
QR Code QR Code

Original Article

만성하지동맥폐색증 환자의 위험인자 및 동반 질환에 따른 개존율 분석

Analyze the Patency Rates according to Risk Factors and Comorbidities in Patients with Chronic Arterial Occlusive Disease in Lower Extremity

정지현1ㆍ황홍필1ㆍ양재도1ㆍ유희철1ㆍ한영민2ㆍ조백환1
Ji Hyun Jung, M.D.1, Hong Pil Hwang, M.D.1, Jae Do Yang, M.D.1, Hee Chul Yu, M.D.1, Young Min Han, M.D.2 and Baik Hwan Cho, M.D.1
Author Info +

Departments of Surgery1 and Radiology2, Chonbuk National University Medical School, Jeonju, Korea

Departments of Surgery1 and Radiology2, Chonbuk National University Medical School, Jeonju, Korea

Korean J Vasc Endovasc Surg 2012; 28(2): 61-67

Published June 30, 2012 https://doi.org/10.5758/kjves.2012.28.2.61

Copyright © The Korean Society for Vascular Surgery.

Article Tools

Share this article on :

Metrics

Article Tools
Article Tools

Abstract

Go to
Purpose: The aim of this study is to analyze the patency rates according to the risk factors and comorbidities in patients treated with endovascular treatments or arterial bypass surgery due to chronic arterial occlusive disease in the lower extremity. Methods: Two hundred fifty-seven patients were treated for chronic arterial occlusive disease in lower extremity from January 2000 to December 2010 at Chonbuk National University Hospital; of the 257 patients, we retrospectively reviewed medical records of 142 patients who could be followed-up. We analyzed the patency rates according to the Trans-Atlantic Inter-Society Consensus (TASC) II classification, risk factors and comorbidities. Results: One year, three year, and five year patency rates according to TASC classification had no statistical significance (P=0.301), and those risk factors and comorbidities associated with each other also had no statistical significance. However, the patency rates according to the number of risk factors and comorbidities demonstrated statistical significance (P=0.004), respectively. In addition, when sum of the total number was above 6, the patency rates were the poorest with statistical significance (P＜0.001). Also, these analyses had statistical significance in the groups regarding TASC C, D (P＜0.001), aorto-iliac lesions (P＜0.001) and femoro-popliteal lesions (P＜0.001). Conclusion: Analysis of risk factors and comorbidities in patients with chronic arterial occlusive disease in the lower extremity can be useful in predicting the patency rates prior to endovascular treatments or arterial bypass surgeries.

Keywords

Chronic arterial occlusive disease, Risk factors and comorbidities, Patency rate

References

Go to
  1. Lee HJ, Kim HT, Choi JS, Kim YW, Park UJ, Cho WH. Comparison of mid-term results of surgical and endovascular treatment for TASC C&D lesions of the iliac artery. J Korean Soc Vasc Surg 2010;26:24-29.
  2. Kim HW, Choi SJ, Chung SY, Kim SG, Yoon W, Kim JK. Result of stent insertion into iliac arterial system: based on TransAtlantic Inter-Society Consensus (TASC) morphologic stratification. J Korean Soc Vasc Surg 2005;21:23-27.
  3. Shin SH, Kwon SH, Cho JH, Ahn HJ, Oh JH, Park HC. Outcomes of bypass surgery versus endovascular therapy for TASC II C and D femoro-popliteal lesions in patients with chronic limb ischemia. J Korean Soc Vasc Surg 2010;26:90-97.
  4. Cho WP, Cha HJ, Kong EM, Jeon YS, Cho SG, Kim JY, et al. Transition of treatment modalities for peripheral arterial occlusive disease for the recent 5 years according to the TASC II classifications in a single institution. J Korean Soc Vasc Surg 2011;27:23-26.
  5. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Section D: chronic critical limb ischaemia. Eur J Vasc Endovasc Surg 2000;19 Suppl A:S144-S243.
  6. Choi DH, Lee SM, Koh SH, Hong SW, Oh SM, Yoon C, et al. Cumulative patency rate of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. J Korean Soc Vasc Surg 2004;20:70-77.
  7. Mannick J, Whittemore AD, Donaldson MC. Aortofemoral bypass for atherosclerotic aortoiliac disease. In: Ernst CB, Stanley JC, editors. Current therapy in vascular surgery. 2nd ed. Philadelphia: B.C. Decker Inc.; 1991. p. 391.
  8. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992;152:56-64.
    Pubmed CrossRef
  9. McGill HC Jr, McMahan CA, Herderick EE, Zieske AW, Malcom GT, Tracy RE, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002;105:2712-2718.
    CrossRef
  10. Lee HH, Moon IS, Park JS, Kim SN, Koh YB. Clinical analysis of femoropopliteal bypass. J Korean Soc Vasc Surg 1997;13:36-41.
  11. Kim YS, Kim DK, Lee TS, Park HC. Infrainguinal reconstruction vs primary amputation in critical limb ischemia. J Korean Soc Vasc Surg 2000;16:61-70.
  12. Taylor LM Jr, Porter JM. Natural history and non-operative treatment of chronic lower extremity ischemia. In: Rutherford RB, editor. Vascular surgery. 3rd ed. Philadelphia: WB Saunders; 1989. p. 656
  13. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic InterSociety Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006;47:1239-1312.
    Pubmed CrossRef
  14. Walden R, Siegel Y, Rubinstein ZJ, Morag B, Bass A, Adar R. Percutaneous transluminal angioplasty: a suggested method for analysis of clinical, arteriographic, and hemodynamic factors affecting the results of treatment. J Vasc Surg 1986;3:583-590.
    CrossRef
  15. Lugmayr HF, Holzer H, Kastner M, Riedelsberger H, Auterith A. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a midterm follow-up. Radiology 2002;222:37-43.
    Pubmed CrossRef
  16. Park KH. Comparison of operative risks between claudicants and critical limb ischemic patients. J Korean Soc Vasc Surg 2003;19:22-26.
  17. Park SJ, Kwon SH, Oh JH, Park HC. Intermediate results of infrainguinal percutaneous transluminal angioplasty. J Korean Soc Vasc Surg 2007;23:19-26.
  18. Cambria RP, Faust G, Gusberg R, Tilson MD, Zucker KA, Modlin IM. Percutaneous angioplasty for peripheral arterial occlusive disease: correlates of clinical success. Arch Surg 1987;122:283-287.
    Pubmed CrossRef
  19. Timaran CH, Prault TL, Stevens SL, Freeman MB, Goldman MH. Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions. J Vasc Surg 2003;38:272-278.
    CrossRef
  20. Ouriel K. Peripheral arterial disease. Lancet 2001;358:12571264.
    CrossRef

Related articles in VSI

More Related Articles